Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Duvillard

Showing results (191-200 of 196) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 196 results.
The Journal of Clinical Endocrinology and Metabolism|June 5, 2008
Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphyS Leboulleux, C Dromain, A L Vataire, et al.
Annales De Dermatologie Et De Venereologie|December 8, 2010
[Melanoma in HIV patients: 14 cases]S Qasmi, C Sutra-Loubet, E Maubec, et al.
Endocrine-Related Cancer|March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinomaJ Hadoux, D Malka, D Planchard, et al.
Gynecologie, Obstetrique & Fertilite|May 22, 2008
[Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ]D Querleu, P Bonnier, P Morice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma GroupP Pautier, A Floquet, L Gladieff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2017
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancerS M de Boer, B G Wortman, T Bosse, et al.
Pageof 20

Showing results (191-200 of 196) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 196 results.
The Journal of Clinical Endocrinology and Metabolism|June 5, 2008
Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphyS Leboulleux, C Dromain, A L Vataire, et al.
Annales De Dermatologie Et De Venereologie|December 8, 2010
[Melanoma in HIV patients: 14 cases]S Qasmi, C Sutra-Loubet, E Maubec, et al.
Endocrine-Related Cancer|March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinomaJ Hadoux, D Malka, D Planchard, et al.
Gynecologie, Obstetrique & Fertilite|May 22, 2008
[Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ]D Querleu, P Bonnier, P Morice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma GroupP Pautier, A Floquet, L Gladieff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2017
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancerS M de Boer, B G Wortman, T Bosse, et al.
Pageof 20